(Q38068701)

English

Effect of IL-17A blockade with secukinumab in autoimmune diseases

scientific article published on 19 December 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

Europe PubMed Central

title

Effect of IL-17A blockade with secukinumab in autoimmune diseases (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28 August 2017

Dhavalkumar D Patel

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

David M Lee

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

Frank Kolbinger

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

Christian Antoni

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

language of work or name

English

0 references

publication date

19 December 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

published in

Annals of the Rheumatic Diseases

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

volume

72 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

page(s)

ii116-23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

cites work

Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1186/AR3466

Identifiers

DOI

10.1136/ANNRHEUMDIS-2012-202371

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

PubMed publication ID

23253932

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23253932

retrieved

28 August 2017

(Q38068701)

Effect of IL-17A blockade with secukinumab in autoimmune diseases

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)